Apolipoprotein E ϵ4 in inclusion body myositis
✍ Scribed by Michael J. Garlepp; Hyacinth Tabarias; Frank M. van Bockxmeer; Paul J. Zilko; Beverley Laing; Frank L. Mastaglia
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 313 KB
- Volume
- 38
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Sporadic inclusion body myositis (S-IBM) is a progressive, acquired disease of unknown etiology. Prior studies have suggested neurogenic involvement based on electrophysiologic data, although the biopsy is compatible with a myopathic process. Quantitative electrophysiologic studies were performed in
A 10-year retrospective review was conducted to ascertain the prevalence of inclusion body myositis (IBM) in Western Australia. Seventeen patients with sporadic IBM aged 45-90 years were identified and the prevalence of IBM was calculated to be 9.3 × 10 -6 . The prevalence was higher in men (10.9 ×